Pfizer (NYSE: PFE) recently announced very good first-quarter results. In this Motley Fool Live video recorded on May 5, Motley Fool contributors Keith Speights and Brian Orelli discuss why Pfizer stock didn't soar after its fantastic Q1 results. Keith Speights: Well, Brian, we talked about this being the thick of earnings season and we've had several big earnings reports already this week.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting